Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Fortis Healthcare Ltd (FORTIS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532843 NSE: FORTIS Hospital & Healthcare Services | Mid Cap | Fortis Healthcare Share Price
₹887.40 -14.40 (-1.60%)
As on 11-Sep'26 15:13
Fortis Healthcare Ltd (FORTIS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532843 NSE: FORTIS Hospital & Healthcare Services | Mid Cap | Fortis Healthcare Share Price
₹887.40 -14.40 (-1.60%)
As on 11-Sep'26 15:13
Key Metrics
Valuation Multiples
Market Cap
₹68,082 Cr.
Current Price
₹887.4
52-Week Low / High
₹767 / 1,105
TTM EPS
₹13.9
TTM Sales
₹9,506 Cr.
Book Value per Share
₹134.6
P/E Ratio
64.97
Lower than its 5-year historical median
Industry PE
100.8
Price to Book (P/B)
6.70
Higher than its 5-year historical median
Price to Sales (P/S)
7.16
Lower than its 5-year historical median
EV/EBITDA
32.28
Lower than its 5-year historical median
Dividend Yield
0.11%
Profitability Efficiency
Return on Equity (ROE)
11.32%
Outperforms industry median
Return on Capital Employed (ROCE)
14.07%
Outperforms industry median
Return on Assets (ROA)
7.29%
Operating Profit Margin
22.8%
Net Profit Margin
11.66%
Gross Profit Margin
20%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
23.97%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
31.3%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
31.48%
Asset Quality
Promoter Holding
31.17%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹9,407 Cr.
Equity
₹755 Cr.
Face Value
₹10
All Time Low / High
₹45.00 / 1105.00
Check Before You Invest
Quality
Very GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Fortis Healthcare Ltd a good quality company?
Fortis Healthcare Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Fortis Healthcare Ltd performance compare with that of its Peers?
Revenue growth of Fortis Healthcare Ltd vs industry peers?
Fortis Healthcare Ltd revenue CAGR is 23.15%, compared to the industry median CAGR of 23.15%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Fortis Healthcare Ltd?
Promoters hold 31.17% of the Fortis Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Fortis Healthcare Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 17.6% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Fortis Healthcare Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -0.2% | 0.1% | 5.1% | 8.1% | 1.7% | 1.3% | 2.3% | 3.5% | 2.2% | 4.3% | - |
| Value Creation Index ⓘ | -1.0 | -1.0 | -0.6 | -0.4 | -0.9 | -0.9 | -0.8 | -0.7 | -0.8 | -0.6 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 645 | 659 | 656 | 702 | 633 | 863 | 1,053 | 1,181 | 1,446 | 1,793 | 1,849 |
| Sales YoY Gr. | - | 2.2% | -0.5% | 6.9% | -9.8% | 36.3% | 22.1% | 12.2% | 22.4% | 24% | - |
| Adj EPS ⓘ | -0.5 | -1.3 | 1.6 | 6.8 | -0.5 | -0.2 | 1.3 | 1.8 | 1.9 | 2.8 | 3 |
| YoY Gr. | - | NA | NA | 320.4% | -107.9% | NA | NA | 39.1% | 7.3% | 45% | - |
| BVPS (₹) ⓘ | 82.1 | 80.9 | 110.4 | 117.6 | 117.6 | 117.5 | 118.7 | 120.4 | 120.2 | 122.2 | 122.9 |
| Adj Net Profit ⓘ | -24.2 | -68.1 | 123 | 514 | -40.5 | -13.1 | 96.7 | 134 | 144 | 209 | 226 |
| Cash Flow from Ops. ⓘ | 21.7 | -14.8 | -61.3 | 99.9 | 31.9 | 76.5 | 198 | 218 | 334 | 116 | - |
| Debt/CF from Ops. ⓘ | 29.8 | -37.5 | -23.7 | 7.2 | 24.4 | 8.4 | 1.9 | 1.4 | 5.3 | 17 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 12% | 23.2% | 19.4% | 24% | ||||
| Adj EPS ⓘ | NA | NA | 29.4% | 45% | ||||
| BVPSⓘ | 4.5% | 0.8% | 1% | 1.7% | ||||
| Share Price | 17.3% | 26.2% | 37.5% | -8.1% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -0.6 | -1.6 | 2 | 6 | -0.5 | -0.2 | 1.1 | 1.5 | 1.6 | 2.3 | 2.5 |
| Op. Profit Mgn % ⓘ | -12.1 | -5.7 | -18.7 | 9.8 | 4.4 | 13.4 | 12.7 | 16.4 | 17.7 | 22.2 | 22.3 |
| Net Profit Mgn % ⓘ | -3.8 | -10.3 | 18.7 | 73.2 | -6.4 | -1.5 | 9.2 | 11.4 | 10 | 11.7 | 12.3 |
| Debt to Equity ⓘ | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0.2 | 0.2 | - |
| Working Cap Days ⓘ | 939 | 536 | 627 | 794 | 756 | 416 | 336 | 294 | 257 | 200 | 34 |
| Cash Conv. Cycle ⓘ | -15 | -37 | -51 | -66 | -72 | -76 | -101 | -132 | -140 | -104 | -59 |
Valuation of Fortis Healthcare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,574 | 4,561 | 4,469 | 4,632 | 4,030 | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 |
| Operating Expenses ⓘ + | 4,221 | 4,288 | 4,244 | 4,023 | 3,626 | 4,649 | 5,196 | 5,625 | 6,195 | 7,043 |
| Operating Profit ⓘ | 353 | 273 | 225 | 610 | 404 | 1,069 | 1,101 | 1,268 | 1,588 | 2,085 |
| Operating Profit Margin (%) | 7.7% | 6.0% | 5.0% | 13.2% | 10.0% | 18.7% | 17.5% | 18.4% | 20.4% | 22.8% |
| Other Income ⓘ + | 166 | 140 | 92 | 53 | 47 | 27 | 62 | 38 | 67 | 51 |
| Interest ⓘ | 229 | 258 | 337 | 205 | 166 | 147 | 129 | 131 | 184 | 314 |
| Depreciation ⓘ | 222 | 239 | 233 | 292 | 291 | 301 | 316 | 342 | 386 | 449 |
| Profit Before Tax ⓘ | 552 | -912 | -110 | 239 | 43 | 988 | 814 | 858 | 1,007 | 1,366 |
| Tax ⓘ | 72 | 23 | 114 | 148 | 99 | 198 | 181 | 213 | 198 | 302 |
| Profit After Tax | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1,064 |
| PAT Margin (%) | 10.5% | -20.5% | -5.0% | 2.0% | -1.4% | 13.8% | 10.1% | 9.4% | 10.4% | 11.7% |
| Adjusted EPS (₹) | 8.1 | -19.5 | -4.0 | 0.8 | -1.5 | 7.4 | 7.8 | 7.9 | 10.3 | 13.8 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 12.80% | 12.60% | 9.80% | 7.30% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 5,126 | 4,034 | 6,577 | 6,657 | 6,118 | 6,176 | 7,241 | 7,661 | 8,915 | 9,894 | |
| Debt + | 1,959 | 1,400 | 1,868 | 1,317 | 1,147 | 949 | 675 | 810 | 2,129 | 2,483 | |
| Minority Interest | 1167 | 1255 | 512 | 544 | 598 | 830 | 858 | 893 | 253 | 273 | |
| Trade Payables | 589 | 763 | 754 | 598 | 548 | 661 | 714 | 728 | 808 | 943 | |
| Others Liabilities ⓘ | 643 | 875 | 1,776 | 1,839 | 2,373 | 2,899 | 2,601 | 2,880 | 1,273 | 2,240 | |
| Total Liabilities ⓘ | 9,484 | 8,327 | 11,486 | 10,955 | 10,784 | 11,516 | 12,089 | 12,971 | 13,377 | 15,833 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 5,419 | 4,995 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 | 10,463 | 12,230 | |
| CWIP ⓘ | 268 | 226 | 450 | 204 | 165 | 193 | 228 | 542 | 407 | 434 | |
| Investments ⓘ | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 | 243 | |
| Inventories | 62 | 67 | 57 | 78 | 77 | 123 | 123 | 107 | 115 | 135 | |
| Trade Receivables | 473 | 470 | 542 | 459 | 458 | 512 | 582 | 628 | 784 | 1,044 | |
| Cash Equivalents | 546 | 220 | 856 | 266 | 417 | 413 | 363 | 598 | 508 | 544 | |
| Others Assets ⓘ | 838 | 617 | 835 | 971 | 683 | 755 | 1,158 | 992 | 930 | 1,203 | |
| Total Assets ⓘ | 9,484 | 8,327 | 11,486 | 10,955 | 10,784 | 11,516 | 12,089 | 12,971 | 13,377 | 15,833 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 966 | 493 | -179 | 172 | 485 | 865 | 822 | 1,100 | 1,424 | 1,601 |
| Cash Flow From Investing Activity ⓘ + | -1,002 | -335 | -3,323 | 60 | -135 | -514 | -374 | -886 | -779 | -1,538 |
| Cash Flow From Financing Activity ⓘ + | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -86 | -714 | 164 |
| Net Cash Flow ⓘ | 224 | -515 | 755 | -630 | 207 | -166 | -23 | 127 | -69 | 227 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 10.33 | -20.4 | -4.22 | 1.38 | -0.88 | 12.85 | 9.44 | 8.66 | 9.77 | 11.32 |
| ROCE (%) | 11.72 | -9.77 | 3.11 | 5.36 | 2.72 | 15.61 | 12.5 | 12.01 | 12.14 | 14.07 |
| Asset Turnover Ratio | 0.55 | 0.51 | 0.45 | 0.41 | 0.37 | 0.51 | 0.53 | 0.55 | 0.59 | 0.62 |
| PAT to CFO Conversion(x) | 2.02 | N/A | N/A | 1.89 | N/A | 1.09 | 1.3 | 1.71 | 1.76 | 1.5 |
| Working Capital Days | ||||||||||
| Receivable Days | 36.60 | 37.70 | 41.40 | 39.40 | 41.50 | 31 | 31.70 | 32 | 33.10 | 36.60 |
| Inventory Days | 4.90 | 5.10 | 5 | 5.30 | 7 | 6.40 | 7.10 | 6.10 | 5.20 | 5 |
| Payable Days | 210.40 | 246.90 | 298.10 | 255.80 | 214.30 | 162.60 | 172.50 | 162.60 | 153.10 | 153 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Fortis Healthcare Ltd FAQs
The current trading price of Fortis Healthcare on 11-Sep-2026 15:13 is ₹887.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Fortis Healthcare stood at ₹68,082.1 Cr
The latest P/E ratio of Fortis Healthcare as of 10-Sep-2026 is 300.9.
The latest P/B ratio of Fortis Healthcare as of 10-Sep-2026 is 7.34.
The 52-week high of Fortis Healthcare is ₹1,105 and the 52-week low is ₹767.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fortis Healthcare is ₹1,849 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Fortis Healthcare Ltd is a good quality company.
The key valuation ratios of Fortis Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Fortis Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Fortis Healthcare Ltd
Fortis Healthcare (FHL) incorporated in 1996 is engaged in running chain of hospitals. FHL started its hospital operations in 2001 through its flagship Mohali Hospital. Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. On November 13, 2018, IHH Healthcare Berhad, Malaysia acquired 31.10% stake in the Company and appointed majority of board of directors, thereby, becoming the controlling shareholder of the Company.
As part of strategic project and digitisation initiative to enhance patient experience and optimise digital assets, the company began implementing an EMR solution to streamline patient health data documentation and sharing. As part of its ongoing commitment to information security, the company deployed next-generation solutions across network for secure network access, application protection, and continuous monitoring. As part of its modernisation journey and to further enhance its digital footprint it undertook key initiatives to upgrade the EUC, network, backend infrastructure, and WAN. These upgrades were designed to strengthen its IT foundation, ensuring higher uptime, faster systems, and improved productivity through greater agility and robustness
Business area of the company
Fortis Healthcare is a leading integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company also holds interests in its subsidiaries, associates and joint ventures which manage and operate a network of multi-specialty hospitals and diagnostics centers.
Awards & Accolades
- 2016-17: Fortis adjudged ‘Hospital of the Year in India’ and ‘Digital Savvy Hospital of the Year’ at the 2016 APAC Healthcare and Medical Tourism Awards.
- 2016-17: Fortis Hospital, BG Road, wins ‘Best Medical Tourism Hospital’ Award.
- 2016-17: Fortis Hospital, Mohali, wins coveted Asia Pacific Hand Hygiene Excellence Award.
- 2016-17: Fortis Escorts Hospital, Jaipur, wins Quality Council of India recognition for the fourth time in a row.
- 2016-17: Fortis C-DOC bags ‘Best Diabetic Care Centre in India’ award for the 3rd time in a row.
- 2016-17: Dr Bidhu K. Mohanti, Director and Head, Radiation Oncology, FMRI, receives Lifetime Achievement Award.
- 2016-17: Fortis creates history at the CII 17th National Awards for Excellence in Energy Management; four hospitals win top honours.
- 2016-17: Fortis Hospital, Ludhiana wins Best Multi-speciality Hospital and Best Quality in Service Delivery awards.
- 2016-17: Fortis Mulund wins two awards each at CIMS Healthcare Excellence and 3rd Asia Healthcare Excellence Awards.
- 2016-17: Dr Narottam Puri receives Lifetime Achievement Award at FICCI 8th Annual Healthcare Excellence Awards, 2016.
- 2017-18: Team Nursing of Fortis Mulund won two prestigious honours at the 7th International Patient Safety Conference, held in Mumbai.
- 2017-18: Two Fortis luminaries, Dr Ashok Seth and Dr Ashok Rajgopal, received the prestigious Dr B. C. Roy National Award from the President of India.
- 2017-18: The Pharmacy Team at Fortis Hospital, Mulund, has received the 'Pharmacie de Qualite' certification and has been honoured with Platinum rating.
- 2017-18: Fortis Healthcare won the prestigious 'Gurgaon Best Employer Brand Award 2017.
- 2017-18: Fortis Hospital, Mulund, won an award for its project, 'One Fortis: Training in Action' at the Asian Hospital Management Awards 2017.
- 2017-18: Fortis Hospitals, Bengaluru, bagged three awards, ‘Best Patient Safety Initiative,’ ‘Best CSR Practices in Healthcare’ and ‘Best Use of Social Media and Digital Marketing’ at Times Television Network - National.
- Marketing Excellence Awards – 2017.
- 2017-18: Fortis Escorts Hospital, Jaipur, won the National Quality Council of India (QCI) D. L. Shah Award for the fifth time in a row.
- 2017-18: Fortis Escorts Hospital, Faridabad, was recognised as the 'Best Heart Hospital' at the Double Helical State Health Awards 2017.
- 2018-19: Fortis Hospital, Mulund, earned the JCI re-accreditation for the fifth time in a row.
- 2018-19: Fortis Healthcare won the ‘Business Process Management (BPM) Asia Master Award’ for the Enterprise level at the BPM Asia Star Championship 2018 organised by CII.
- 2018-19: Fortis Healthcare received the prestigious FICCI Healthcare Excellence Awards 2018 in the Social Initiative category for the 'Umeed Dhadkan' programme.
- 2018-19: Fortis Healthcare's MORETOGIVE ad film won a Bronze at the Indian Content Marketing Awards.
- 2018-19: Fortis Hospital, BG Road, Bengaluru, was ranked by the Medical Travel Quality Alliance (MTQUA) as one of the Top 10 World’s Best Hospitals for Medical Tourism for 2018.
- 2018-19: For the fifth consecutive year, Fortis C-DOC, New Delhi, was named the ‘Best Hospital in India Diabetic Care’ recognition at the Current Index of Medical Specialities Healthcare Excellence Awards 2018.
- 2019-20: Economic Times Healthworld Hospital Awards’20.
- 2019-20: FICCI Medical Travel Value Awards 2019.
- 2019-20: Excellence in Cardiac Sciences.
- 2019-20: Joint Commission International (JCI) accreditation.
- 2019-20: National Award for Excellence in Energy Management, 2019.
- 2019-20: Best Hospital to Work For.
- 2019-20: International Patient Safety Congress.
- 2019-20: Most Trusted Diagnostic Centre of the Year.
- 2020-21: Fortis Escorts Heart Institute, Okhla Road, New Delhi, featured in Newsweek’s Best Hospitals 2021 - Top Specialised hospitals list for Cardiology speciality.
- 2020-21: Fortis Hospital, Mohali, was recognised by the International Hospital Federation as one of the 100 hospitals globally that went beyond the ‘Call of Duty’ during the COVID-19 pandemic.
- 2020-21: The Department of Urology at Fortis Hospitals, Bengaluru, has been ranked 7th in the country and 3rd in South India by Times Health Survey – All India Critical Care Hospital Ranking Survey 2021.
- 2021-22: ortis Memorial, Gurugram, was the only Indian hospital to feature on Newsweek’s top 25 ‘World’s Best Smart Hospitals 2021’ list.
- 2021-22: Fortis Escorts, New Delhi, received the AHPI Award 2021 for Excellence in Healthcare.
- 2021-22: Fortis hospitals won eight National and Regional level awards at the Economic Times Healthcare Awards 2021.
- 2022-23: Fortis Memorial Research Institute, Gurugram, Fortis Hospital, Mulund, Fortis Hospital, Mohali and Fortis Escorts Heart Institute, Okhla, New Delhi received prestigious AHPI Awards for Excellence in Healthcare-2022.
- 2022-23: COVID newsletter, ‘Fortis Healing Touch,’ was adjudged the ‘Best Internal Communications Campaign - Healthcare’ at the PRmoment India Health Comms Awards 2022.
- 2022-23: Fortis Mohali won the National Award for Excellence in Energy Management-2022 for the record 8th time.
- 2022-23: Fortis Escorts, Okhla Road, Fortis Memorial, Gurugram, Fortis Vasant Kunj, Fortis Ludhiana and Fortis Noida received AHPI’s coveted ‘Excellence Award 2023.’
- 2023-24: Fortis Healthcare wins seven awards in the Medical Value Travel Specialist Hospital category at Advantage Healthcare India’s Medical Value Travel Awards 2023.
- 2023-24: Fortis Mulund, Fortis Anandapur and Fortis Mohali win multiple awards at CAHOCON 2023.
- 2023-24: Fortis Corporate Communications wins ‘BW Healthcare Award for Institutional Excellence in Healthcare Marketing.
- 2023-24: Fortis Hospital Mulund bags two awards at Regional Federation of Critical Care Nursing SAARC Conference 2024.
- 2023-24: Fortis Memorial Research Institute, Gurugram, is honoured with Odisha Chief Minister’s Award for Excellence in Healthcare Services.
- 2024-25: Fortis Healthcare was awarded a Certificate of Excellence under the category of ‘Top 3 Green Transition Stories’ by Tata Power-DDL (Delhi Distribution Limited), recognising commitment to sustainable practices across all facilities.
- 2024-25: Fortis Healthcare was recognised with ‘Best ESG Initiatives to Implement Energy Efficiency’ and ‘Best ESG Performance in Healthcare’ awards at the 5th Annual ESG Summit & Awards, 2024, held in New Delhi.
- 2024-25: Fortis Hospital, Mulund, received the prestigious JCI re-accreditation for the 7th consecutive time. Fortis Mulund is the third hospital in the country to secure seven consecutive re-accreditations.
- 2024-25: Six Fortis hospitals were ranked amongst top 100 hospitals in Newsweek’s ‘Best Specialised Hospitals – Asia Pacific 2024’ list.
Milestones
- 2008: Fortis Hospital, Noida Becomes first hospital In Uttar Pradesh to receive the coveted NABH Accredita.
- 2008: Fortis Escorts Becomes First Hospital in Faridabad to Launch Total Knee Replacement Unit.
- 2009: Announces taking over of the operational and management control of the 200-bed Apollo Modi Hospital in Kota (Rajasthan) for providing superior healthcare services in the region.
- 2009: Launches dental centre at Malar Hospital, Chennai, with the aim of promoting dental tourism in the city. The Fortis Dental Centre has been floated on partnership basis with dental chain Axiss Dental.
- 2010: Completes acquisition of 23.9% stake in Parkway Holdings.
- 2010: Divests entire stake in Parkway to Khazanah.
- 2010: Adds cancer institute in its hospital portfolio.
- 2010: Inks pact with Republic Of Burundi.
- 2010: Inks MOU with RAK Hospital and Tanzania's RMC.
- 2010: Strengthens presence in Central India Network; touches 50 hospitals mark.
- 2010: Acquires O P Jindal Hospital in Raigarh, Chhattisgarh.
- 2010: Unveils new hospital in Shalimar Bagh in Delhi.
- 2010: Adds Vivekanand Hospital to its network.
- 2011: Signs MoU with Utah University for specialized care in emergency medicine.
- 2011: Changes name of company from Fortis Healthcare Ltd to Fortis Healthcare (India) Ltd.
- 2011: Adds 100 bed Lifeline Hospital at Alwar in Rajasthan.
- 2011: Fortis Healthcare Ltd acquired Super Religare Laboratories (SRL), South-east Asia's largest diagnostics laboratory network to further strengthen presence across the healthcare value chain.
- 2012: Fortis Healthcare Ltd acquired Fortis Healthcare International Pte. Ltd.-Fortis Healthcare Ltd launched the first colorectal hospital in Singapore, becoming the first Indian hospital chain with a greenfield hospital abroad'.
- 2017: Fortis Healthcare and wayForward collaborate on a unique emotional wellness programme to combat workplace stress.
- 2018: Board of Fortis Healthcare approves the binding investment proposal from IHH Healthcare for an investment of Rs 4,000 crore at a per share price of Rs 170.
- 2019: Fortis join hands with Tips for #Music4MentalHealth Initiative.
- 2019: Fortis School Mental Health Programme initiates internship for students.
- 2020: Fortis rolls out e-Consultations for remote patient care in 23 hospitals across multiple locations in India.
- 2022: Fortis Healthcare to add around 1,500 beds over next five years.
- 2023: Fortis Healthcare signs definitive agreements for acquisition of Medeor Hospital in Manesar.
- 2023: Fortis Healthcare partners with emergency response network RED.Health.
- 2024: Fortis Healthcare acquires 7.61% stake in Agilus Diagnostics.
- 2025: Fortis Healthcare’s arm to acquire entire business operations of Shrimann Superspecialty Hospital.
- 2025: Fortis Healthcare enters into O&M services agreement with GHIPL.
- 2025: Fortis Healthcare signs collaboration agreement with Ekana Group.
- 2025: Fortis Healthcare’s arm inks lease agreement with RR Lifesciences.
- 2025: Fortis Healthcare inks pact to acquire People Tree Hospital in Bengaluru.
You have 34 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
